PURPOSE: To evaluate psychometric properties of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) questionnaire, a 47-item disease-specific instrument evaluating Health-Related Quality of Life (HRQL) in human immunodeficiency virus (HIV)-infected patients. METHODS: Treatment-experienced HIV-infected patients from two clinical programmes (N = 565; N = 1,096) completed the FAHI at Baseline and after 24 weeks of treatment. Psychometric properties of the FAHI were assessed in both trial populations, including minimal important differences (MIDs) calculations. Links between HRQL assessed by FAHI Total score, and biological endpoints were explored by regression analysis and mean score comparisons. RESULTS: Cronbach's alphas ranged from 0.72 to 0.94. Most items met convergent and discriminant validity criteria. Better FAHI scores were seen for patients in earlier HIV stages. Responsiveness was demonstrated with changes in FAHI scores significantly linked to change in EQ-5D score. Depending on methods used, MIDs ranged from 3.2 to 14 for FAHI Total score. Small association was found between FAHI Total score and CD4 count and viral load (r-square < 3%). Mean changes in FAHI scores were not statistically related to viral response. CONCLUSIONS: The FAHI demonstrated acceptable psychometric properties in two independent populations. HRQL assessment enabled detection of changes in patients' health status not revealed by traditional efficacy endpoints.
PURPOSE: To evaluate psychometric properties of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) questionnaire, a 47-item disease-specific instrument evaluating Health-Related Quality of Life (HRQL) in human immunodeficiency virus (HIV)-infectedpatients. METHODS: Treatment-experienced HIV-infectedpatients from two clinical programmes (N = 565; N = 1,096) completed the FAHI at Baseline and after 24 weeks of treatment. Psychometric properties of the FAHI were assessed in both trial populations, including minimal important differences (MIDs) calculations. Links between HRQL assessed by FAHI Total score, and biological endpoints were explored by regression analysis and mean score comparisons. RESULTS: Cronbach's alphas ranged from 0.72 to 0.94. Most items met convergent and discriminant validity criteria. Better FAHI scores were seen for patients in earlier HIV stages. Responsiveness was demonstrated with changes in FAHI scores significantly linked to change in EQ-5D score. Depending on methods used, MIDs ranged from 3.2 to 14 for FAHI Total score. Small association was found between FAHI Total score and CD4 count and viral load (r-square < 3%). Mean changes in FAHI scores were not statistically related to viral response. CONCLUSIONS: The FAHI demonstrated acceptable psychometric properties in two independent populations. HRQL assessment enabled detection of changes in patients' health status not revealed by traditional efficacy endpoints.
Authors: Richard Haubrich; Dan Berger; Philippe Chiliade; Amy Colson; Marcus Conant; Joel Gallant; Timothy Wilkin; Jeffrey Nadler; Gerald Pierone; Michael Saag; Ben van Baelen; Eric Lefebvre Journal: AIDS Date: 2007-03-30 Impact factor: 4.177
Authors: Richard Shikiar; Mary Kaye Willian; Martin M Okun; Christine S Thompson; Dennis A Revicki Journal: Health Qual Life Outcomes Date: 2006-09-27 Impact factor: 3.186
Authors: Andrew Tomita; Nigel Garrett; Lise Werner; Jonathan K Burns; Lindiwe Mpanza; Koleka Mlisana; Francois van Loggerenberg; Salim S Abdool Karim Journal: AIDS Behav Date: 2014-06
Authors: Judith Feinberg; Michael Saag; Kathleen Squires; Judith Currier; Robert Ryan; Bruce Coate; Joseph Mrus Journal: AIDS Res Treat Date: 2011-08-28
Authors: Moses K Nyongesa; Antipa Sigilai; Amin S Hassan; Janet Thoya; Rachael Odhiambo; Fons J R Van de Vijver; Charles R J C Newton; Amina Abubakar Journal: PLoS One Date: 2017-04-05 Impact factor: 3.240
Authors: Moses K Nyongesa; Paul Mwangi; Stanley W Wanjala; Agnes M Mutua; Hans M Koot; Pim Cuijpers; Charles R J C Newton; Amina Abubakar Journal: Health Qual Life Outcomes Date: 2020-06-05 Impact factor: 3.186
Authors: Blair Olson; Wilson Vincent; Jaimie P Meyer; Trace Kershaw; Kathleen J Sikkema; Timothy G Heckman; Nathan B Hansen Journal: Qual Life Res Date: 2019-08-24 Impact factor: 4.147
Authors: Sarah-Jane Anderson; Miranda Murray; David Cella; Robert Grossberg; Debbie Hagins; William Towner; Marcia Wang; Andrew Clark; Amy Pierce; Cyril Llamoso; Peter Ackerman; Max Lataillade Journal: Patient Date: 2021-06-28 Impact factor: 3.883